A combination of treatments improves recovery after severe stroke

by Fundació Clínic per a la Recerca Biomèdica

A study coordinated by Clínic‑IDIBAPS and published in JAMA demonstrates that adding a pharmacological treatment to thrombectomy improves functional recovery in patients with severe ischemic stroke...

Read more

Patient‑centred materials design: impact on recruitment and adherence

by Sermes CRO

The way a clinical trial is communicated to patients determines its viability from the very outset. Before assessing inclusion criteria or protocol complexity, patients need to understand what is bein...

Read more

Clinical Trials in an Intensive Care Unit: Challenges and Successful Implementation

by Pivotal

Clinical trials in the Intensive Care Units (ICUs) are among the most complex and demanding studies in clinical research. The scientific rationale for studying interventions in critically ill patients...

Read more

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026

by Oryzon Genomics

In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission rate (CRc) of 93% (with 79% CR), and an estimated 12-mon...

Read more

Werfen y Oxford Nanopore establecen una colaboración estratégica para impulsar el desarrollo de ensayos de trasplantes avanzados

by Werfen

La colaboración combina los ensayos de trasplante validados de Werfen con la tecnología de secuenciación de Oxford Nanopore para ofrecer resultados rápidos y de alta resolución, esenciales para u...

Read more

Impact of financial compensation on patient recruitment and retention in clinical trials

by Sermes CRO

In the day-to-day conduct of clinical trials, one of the factors that most strongly affects patient recruitment and retention is not the scientific design of the protocol, but rather the indirect fina...

Read more

Un ensayo clínico pionero tratará de revertir el mal pronóstico de tumores cerebrales infantiles con oncovirus

by Cima Universidad de Navarra

Este estudio en fase 2 impulsado por el Cancer Center Clínica Universidad de Navarra pretende abrir nuevas vías terapéuticas frente a estas enfermedades sin cura y que necesitan más apoyo para la ...

Read more

ORYZON reports financial results and corporate update for quarter ended March 31st, 2026

by Oryzon Genomics

Updated positive data from iadademstat in 1L AML unfit patients to be presented at EHA, with 100% ORR, 93% CRc and 79% strict CR at abstract submission cut-off

Read more

El Instituto de Investigación del Hospital público 12 de Octubre identifica una molécula capaz de frenar la resistencia al tratamiento en un linfoma agresivo

by Hospital Universitario 12 de Octubre

Se ha descubierto que la molécula miR-28 actúa como un potente inhibidor de la resistencia al fármaco ibrutinib en el Linfoma Difuso de Células B Grandes (LDCBG) de tipo ABC, el subtipo más agres...

Read more

Target Cell Models for CAR-T & CAR-NK Validation

by Tebubio

Accelerate functional assays with a specialized ecosystem of native tumor lines, engineered antigens, and quantitative reporter systems.

Read more

How to Manage Trials in Small Populations: Lessons from Rare Diseases

by Sermes CRO

Managing a clinical trial with a limited population requires rethinking many of the usual assumptions of clinical research. When the number of potential patients is small, every methodological, operat...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream